Lapanix 250 MG (Lapatinib) Tablets

Lapanix 250 MG (Lapatinib) Tablets - Effective treatment for HER2-positive breast cancer by Beacon Pharmaceuticals, available from Onco Solution

Lapanix 250 MG (Lapatinib) Tablets

Product ID: 2956

Introduction to Lapanix 250 MG (Lapatinib) Tablets:

Lapanix 250 MG, expertly formulated by Beacon Pharmaceuticals Ltd. and supplied by Onco Solution, is a potent medication designed for the treatment of HER2-positive breast cancer. Lapatinib, the active ingredient, is a tyrosine kinase inhibitor that specifically targets HER2 receptors, playing a crucial role in inhibiting cancer cell growth.

Description: Lapanix 250 MG (Lapatinib) Tablets:

Lapanix 250 MG contains Lapatinib, a dual tyrosine kinase inhibitor that targets both the HER2/neu and epidermal growth factor receptor (EGFR) pathways. By inhibiting these receptors, Lapatinib helps to block the signals that promote the growth and proliferation of cancer cells.

Benefits of Lapanix 250 MG (Lapatinib) Tablets:

  • Targeted Therapy: Specifically inhibits HER2 and EGFR pathways, reducing tumor growth.
  • Effective Combination: Often used in combination with other therapies for enhanced efficacy.
  • Prolonged Survival: Helps extend progression-free survival in patients with advanced breast cancer.

Clinical Use:

Lapanix 250 MG is primarily indicated for:

  • HER2-Positive Breast Cancer: Treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2.
  • Combination Therapy: Often used in combination with other chemotherapeutic agents or hormone therapies.

Dosage and Administration:

The appropriate dosage of Lapanix 250 should be determined by a healthcare professional based on the patient’s condition and response to treatment. It is typically taken once daily, preferably at the same time each day, and should be swallowed whole with a glass of water, either one hour before or one hour after a meal.

Manufacturer: Beacon Pharmaceuticals Ltd.:

Beacon Pharmaceuticals Ltd. is renowned for producing high-quality pharmaceutical products. Their commitment to rigorous quality control and innovative research ensures that Lapanix 250  meets the highest standards of efficacy and safety.

Supplier: Onco Solution:

Onco Solution, the reliable supplier of Lapanix 250 MG, guarantees the availability of this essential medication to healthcare providers and patients. Their dedication to excellence in distribution ensures timely and reliable access to Lapanix.

Storage Conditions:

  • Store Lapanix 250 tablets at room temperature (20°C to 25°C).
  • Keep in a cool, dry place away from direct sunlight and moisture.
  • Keep out of reach of children.

Conclusion:

Lapanix 250 MG (Lapatinib) Tablets provide an effective solution for the treatment of HER2-positive breast cancer. Manufactured by Beacon Pharmaceuticals Ltd. and supplied by Onco Solution, this medication targets key pathways involved in cancer cell growth, offering a potent option for managing advanced breast cancer. Trust Lapanix for comprehensive and targeted cancer therapy.

Related Products:

Contact Us

error: Content is protected !!
Lapanix 250 MG (Lapatinib) Tablets - Effective treatment for HER2-positive breast cancer by Beacon Pharmaceuticals, available from Onco Solution

Request quote Now